Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/227246 
Year of Publication: 
2020
Series/Report no.: 
IZA Discussion Papers No. 13719
Publisher: 
Institute of Labor Economics (IZA), Bonn
Abstract: 
Over 400,000 children die annually from neonatal sepsis, despite several RCTs finding that this can be prevented by chlorhexidine cord care (CHX) for only US$0.23 per dose. Unresolved heterogeneity in findings and other RCT scalability concerns contribute to slow CHX adoption. Studying the first national CHX roll-out — in Nepal — we find that CHX reduces neonatal mortality by 56 percent for births predicted to take place at home. We find no effect for predicted health facility births, which is consistent with heterogeneity in prior experimental estimates. Conditional on predicted place of delivery, there is little significant treatment effect heterogeneity.
Subjects: 
neonatal mortality
chlorhexidine
Nepal
JEL: 
I18
J13
O15
Document Type: 
Working Paper

Files in This Item:
File
Size
2.97 MB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.